Pathophysiological Basis for Antioxidant Therapy in Chronic Liver Disease

Author： Medina Jesús   Moreno-Otero Ricardo  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.17, 2005-01, pp. : 2445-2461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current and Future Therapy for Chronic Hepatitis C Virus Liver Disease

By  

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 247-253

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria in Chronic Liver Disease

By  

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 879-893

Bentham Science Publishers

Access to resources Recommend Favorite

Adiponectin, Structure, Function and Pathophysiological Implications in Non-Alcoholic Fatty Liver Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 6, 2006-06 ,pp. : 651-656

Bentham Science Publishers

Access to resources Recommend Favorite

The Metabolic Syndrome and Chronic Liver Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 5010-5024

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease

By  

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1301-1314

Bentham Science Publishers

Access to resources Recommend Favorite